Skip to content

Clinical trials

Completed Lysosomal Storage Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lysosomal Storage Diseases Status: Completed Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20081
20101
20114
20142
20171
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.3
BioMarin Pharmaceutical2
Shire2
Pfizer1
Sangamo Therapeutics1
Sumitomo Pharma Switzerland GmbH1
Takeda1
The Hospital for Sick Children1
University of Pennsylvania1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lysosomal Storage Diseases13
Cholesterol Ester Storage Disease3
Mucopolysaccharidosis II3
Sudden Infant Death3
Wolman Disease3
Genetic Diseases, Inborn2
Infant, Newborn, Diseases2
Lipid Metabolism Disorders2
Lipidoses2
Metabolic Diseases2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.